Breaking News, Collaborations & Alliances

High Purity New England & Univercells Technologies Unveil Bioprocessing Solutions

New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

High Purity New England (HPNE), a supplier of solutions for the biopharma industry, has officially introduced a new line of fixed-bed, single-use bioreactors from Univercells Technologies for the U.S. Market. This new highly scalable line of bioreactors is designed to ensure seamless scalability from early process development to commercial manufacturing. The scale-X fixed-bed bioreactor range and the NevoLine Upstream platform are available immediately in the U.S. market through High Purity New ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters